Background: Lupus nephritis (LN) is the most severe organ manifestations of systemic lupus
erythematosus (SLE). Although increased knowledge of the disease pathogenesis has …

Background Lupus nephritis is usually manifested by proteinuria, active urinary sediment,
hypertension, and renal failure and is a serious complication with more than 50 …

Lupus nephritis (LN) is a significant cause of various acute and chronic renal diseases,
which can eventually lead to end-stage renal disease. The pathogenic mechanisms of LN …

Animal and human studies have suggested the potential of mesenchymal stromal cells
(MSCs) to treat systemic lupus erythematosus (SLE). Here, we present the results of …

Systemic lupus erythematosus (SLE) is a rare, heterogeneous autoimmune and
autoinflammatory disease that affects both sexes and all races, although this disease …

Mesenchymal stem cells (MSCs) are now known to display not only adult stem cell
multipotency but also robust anti-inflammatory and regenerative properties. After …

Adult tissue-derived mesenchymal stromal cells (MSCs) are showing promise in clinical
trials for systemic lupus erythematosus (SLE). However, the inability to manufacture large …

Systemic lupus erythematosus (SLE) is a chronic autoimmune and inflammatory disorder
with involvement of several organs and systems such as the kidney, lung, brain and the …

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the
production of autoantibodies to components of the cell nucleus. These autoantibodies are …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Although previous
studies have demonstrated that SLE is related to the imbalance of cells in the immune …